Provided by Tiger Trade Technology Pte. Ltd.

Commercial Metals

63.58
+0.86001.37%
Post-market: 63.580.00000.00%19:30 EDT
Volume:917.71K
Turnover:58.39M
Market Cap:7.06B
PE:12.08
High:64.22
Open:63.34
Low:63.15
Close:62.72
52wk High:84.87
52wk Low:53.08
Shares:111.05M
Float Shares:109.72M
Volume Ratio:0.78
T/O Rate:0.84%
Dividend:0.77
Dividend Rate:1.21%
EPS(TTM):5.26
EPS(LYR):0.7400
ROE:13.79%
ROA:6.32%
PB:1.56
PE(LYR):85.92

Loading ...

Fake 'CMC Tokens' Trigger Crypto Scam Alert From CoinMarketCap

utoday
·
May 13

Press Release: Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates

Dow Jones
·
May 13

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

GlobeNewswire
·
May 13

Press Release: Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 12

Press Release: AN2 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

Dow Jones
·
May 12

Table: CMC Magnetics Apr Rev NT$601.8M Vs NT$611.1M

Dow Jones
·
May 11

CMC Corp Sees 1H Parent Pretax Y2.00B

Dow Jones
·
May 07

CMC Markets Executives Acquire Shares Under UK Incentive Plan

TIPRANKS
·
May 06

Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 06

Fate Therapeutics Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of FT819

GlobeNewswire
·
May 05

YD Bio Limited Reports Full Year 2025 Financial Results

GlobeNewswire
·
May 01

Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update

GlobeNewswire
·
Apr 30

Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®

GlobeNewswire
·
Apr 29

Everton line up CMC Markets as shirt sponsor in £30m deal

cityam
·
Apr 28

Alterity Wins FDA Backing on CMC Plan for ATH434 Phase 3 in Multiple System Atrophy

TIPRANKS
·
Apr 27

The Elmet Group Co. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
Apr 24

Grace Therapeutics: Buy Rating Maintained as Addressable CMC Setback Delays but Does Not Derail GTx‑104 Value Thesis

TIPRANKS
·
Apr 24

Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104

GlobeNewswire
·
Apr 24

CMC Magnetics Sells Stake in Phison Electronics Worth NT$306 Million; Shares Drop 5%

MT Newswires Live
·
Apr 23

Bayer: Askbio's Viralgen To Supply Drug Product For Regenerate-PD Investigational Gene Therapy Phase Ii Trial

Reuters
·
Apr 20